Skip to main content

Pregnant Women, Influenza

Flucelvax Pregnancy Registry
NCT02258178 | PHASE 3 | OBSERVATIONAL

The goal of the registry is to develop a better understanding of the safety of Flucelvax in women and their offspring who were exposed to the vaccine during pregnancy

Trial Information
1 Sites
0 Participants
Recruiting
18 Years to 12 Years

If interested, contact clinicaltrials@cslbehring.com for more information

CSL Behring respects your privacy. For an explanation of how CSL Behring will use the information you are submitting, please view our Privacy Policy

PPD
Wilmington,North Carolina,United States,28401

Study Eligibility Criteria

Additional Studies

Additional studies can be found at ClinicalTrials.gov